🌍·4h agoMedia
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Publisher
N
Novartis
Global
This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Novartis
- Region
- Global
- Scope
- Media
- Published
- September 18, 2026
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on novartis.com
Leave the platform to read the original full article on the publisher site.
Source: Novartis
Scope: Media
Related coverage
More related coverage
University of Minnesota/2h ago
Glass Pumpkin Patch at the Arboretum
Certara/3h ago
When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing
Certara/3h ago
Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers
schaeffersresearch.com/3h ago